Electronic Adverse Event Filing Could Be Phased In Over Four Years - FDA
Executive Summary
FDA is suggesting a four-year phase-in for mandatory electronic submissions to its adverse event reporting system in an advanced notice of proposed rule-making (ANPR) published in the Nov. 5 Federal Register.